51 related articles for article (PubMed ID: 432371)
1. Increased serum methadone levels in humans during naloxone-precipitated withdrawal [proceedings].
Resnick RB; Washton A; Verebey K; Mule SJ
Psychopharmacol Bull; 1979 Apr; 15(2):42-4. PubMed ID: 432371
[No Abstract] [Full Text] [Related]
2. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
[TBL] [Abstract][Full Text] [Related]
3. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
Hine B; Torrelio M; Gershon S
Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
[TBL] [Abstract][Full Text] [Related]
5. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
6. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
[TBL] [Abstract][Full Text] [Related]
7. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
[TBL] [Abstract][Full Text] [Related]
8. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
Iwamoto ET; Loh HH; Way EL
J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
[TBL] [Abstract][Full Text] [Related]
9. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
NIDA Res Monogr; 1987; 76():157-61. PubMed ID: 2449617
[No Abstract] [Full Text] [Related]
10. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
Wright C; Bigelow GE; Stitzer ML
NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
[No Abstract] [Full Text] [Related]
11. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats.
Chang AP; Dixon WR
J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117
[TBL] [Abstract][Full Text] [Related]
12. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
13. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
[TBL] [Abstract][Full Text] [Related]
14. Proceedings: Aversive properties of naloxone in morphine-treated rats.
Pilcher CW; Stolerman IP
Br J Pharmacol; 1975 Jun; 54(2):235P. PubMed ID: 1170913
[No Abstract] [Full Text] [Related]
15. Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
Way EL; Loh HH; Ho IK; Iwamoto ET; Wei E
Adv Biochem Psychopharmacol; 1973; 8(0):455-69. PubMed ID: 4604812
[No Abstract] [Full Text] [Related]
16. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
Frederickson RC; Hewes CR; Aiken JW
J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
[TBL] [Abstract][Full Text] [Related]
18. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
Cox B; Ary M; Lomax P
J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
[TBL] [Abstract][Full Text] [Related]
19. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
Smits SE
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]